Entacapone and Squamous cell carcinoma of skin - a phase IV clinical study of FDA data

Summary:

Squamous cell carcinoma of skin is reported only by a few people who take Entacapone.

The phase IV clinical study analyzes which people take Entacapone and have Squamous cell carcinoma of skin. It is created by eHealthMe based on reports of 3,385 people who have side effects while taking Entacapone from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

3,385 people reported to have side effects when taking Entacapone.
Among them, 2 people (0.06%) have Squamous cell carcinoma of skin.

What is Entacapone?

Entacapone has active ingredients of entacapone. It is often used in parkinson's disease. eHealthMe is studying from 3,407 Entacapone users for its effectiveness, alternative drugs and more.

What is Squamous cell carcinoma of skin?

Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin) is found to be associated with 1,174 drugs and 580 conditions by eHealthMe.

Number of Entacapone and Squamous cell carcinoma of skin reports submitted per year:

Could Entacapone cause Squamous cell carcinoma of skin?

Gender of people who have Squamous cell carcinoma of skin when taking Entacapone *:

female: 0.0 %
male: 100 %

Age of people who have Squamous cell carcinoma of skin when taking Entacapone *:

Common drugs people take besides Entacapone *:

Vitamin D3: 1 person, 50.00%
Sertraline: 1 person, 50.00%
Duopa: 1 person, 50.00%

Common conditions people have *:

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Entacapone and have Squamous cell carcinoma of skin?

Check whether Squamous cell carcinoma of skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Squamous cell carcinoma of skin and when was it recovered:

Squamous cell carcinoma of skin in Entacapone

Expand to all the drugs that have ingredients of entacapone:

Squamous cell carcinoma of skin and drugs with ingredients of entacapone

Alternative drugs to, pros and cons of Entacapone:

Entacapone (3,407 reports)

Common Entacapone side effects:

Browse all side effects of Entacapone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Squamous cell carcinoma of skin treatments and more:

Squamous cell carcinoma of skin (6,645 reports)

COVID vaccines that are related to Squamous cell carcinoma of skin:

Common drugs associated with Squamous cell carcinoma of skin:

All the drugs that are associated with Squamous cell carcinoma of skin:

Squamous cell carcinoma of skin (1,174 drugs)

Common conditions associated with Squamous cell carcinoma of skin:

All the conditions that are associated with Squamous cell carcinoma of skin:

Squamous cell carcinoma of skin (580 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entacapone (the active ingredients of Entacapone) and Entacapone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.